Anna Jabłecka
Impact in
-
- Tea Polyphenols and Effects
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
- Physiology 14
- Nitric Oxide and Endothelin Effects 10
- Smoking Behavior and Cessation 3
-
- Blood Pressure and Hypertension Studies 4
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Heart Failure Treatment and Management 3
- Co-authors
- Paweł Bogdański (25 shared papers)Danuta Pupek‐Musialik (16 shared papers)Joanna Suliburska (10 shared papers)Monika Szulińska (4 shared papers)Artur Robert Cieślewicz (24 shared papers)Katarzyna Musialik (4 shared papers)Stanisław Nowak (1 shared paper)Anna‐Maria Barciszewska (1 shared paper)
- Journals
- Pharmacological Reports (6 papers)Therapeutics and Clinical Risk Management (2 papers)Biological Trace Element Research (2 papers)Vaccines (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- PolandUnited States
In The Last Decade
Anna Jabłecka
59 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Pathology and Forensic Medicine 262
- Biochemistry 95
- Cardiology and Cardiovascular Medicine 145
- Rehabilitation 38
- Nutrition and Dietetics 72
Countries citing papers authored by Anna Jabłecka
This map shows the geographic impact of Anna Jabłecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jabłecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jabłecka more than expected).
Fields of papers citing papers by Anna Jabłecka
This network shows the impact of papers produced by Anna Jabłecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jabłecka. The network helps show where Anna Jabłecka may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Jabłecka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 282 | |
| 2 | 2012 | 165 | |
| 3 | Global DNA methylation changes in blood of patients with essential hypertension. | 2010 | 109 |
| 4 | Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity. | 2012 | 50 |
| 5 | 2013 | 38 | |
| 6 | The effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremities. | 2012 | 37 |
| 7 | 2010 | 33 | |
| 8 | 2021 | 30 | |
| 9 | Effect of L-arginine supplementation on insulin resistance and serum adiponectin concentration in rats with fat diet. | 2015 | 27 |
| 10 | 2007 | 26 | |
| 11 | 2007 | 26 | |
| 12 | 2016 | 26 | |
| 13 | The influence of two different doses of L-arginine oral supplementation on nitric oxide (NO) concentration and total antioxidant status (TAS) in atherosclerotic patients. | 2004 | 24 |
| 14 | 2012 | 23 | |
| 15 | 2013 | 23 | |
| 16 | Neopterin as a prognostic marker in patients with chronic heart failure. | 2010 | 16 |
| 17 | 2013 | 16 | |
| 18 | Prognostic usefulness of IL-6 and VEGF for the occurrence of changes in coronary arteries of patients with stable angina and implanted stents. | 2014 | 15 |
| 19 | 2019 | 14 | |
| 20 | 2015 | 10 |
About Anna Jabłecka
Anna Jabłecka is a scholar working on Physiology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Epidemiology and Geriatrics and Gerontology, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (10 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers), Cardiac Ischemia and Reperfusion (5 papers), Blood Pressure and Hypertension Studies (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Smoking Behavior and Cessation (3 papers), Heart Failure Treatment and Management (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (262 citations), Biochemistry (95 citations), Cardiology and Cardiovascular Medicine (145 citations), Rehabilitation (38 citations) and Nutrition and Dietetics (72 citations). Anna Jabłecka has collaborated with scholars based in Poland and United States. Frequent co-authors include Paweł Bogdański, Danuta Pupek‐Musialik, Joanna Suliburska, Monika Szulińska, Artur Robert Cieślewicz, Katarzyna Musialik, Stanisław Nowak, Anna‐Maria Barciszewska, Eliza Wyszko and Mirosława Z. Barciszewska. Their work appears in journals such as Pharmacological Reports, Therapeutics and Clinical Risk Management, Biological Trace Element Research, Vaccines and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.